Poolbeg Pharma (POLB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.15p
   
  • Change Today:
    -0.60p
  • 52 Week High: 14.25
  • 52 Week Low: 2.40
  • Currency: UK Pounds
  • Shares Issued: 500.00m
  • Volume: 4,318,655
  • Market Cap: £15.75m
  • Beta: 0.03

Regulatory News

FDA Orphan Drug Designation granted for POLB 001 27-May-2025 07:01 RNS
Annual Report, AGM Notice & Circular 27-May-2025 07:00 RNS
Result of upsized oversubscribed BookBuild Offer 23-May-2025 07:00 RNS
Increase of BookBuild Offer 22-May-2025 13:44 RNS
Result of Placing and Notice of General Meeting 20-May-2025 12:26 RNS
Proposed Retail Offer to raise up to £100,000 20-May-2025 07:02 RNS
Proposed Fundraising to raise approximately ... 20-May-2025 07:01 RNS
Results for the year ended 31 December 2024 20-May-2025 07:00 RNS
Form 8.5 (EPT/NON-RI) 25-Feb-2025 08:50 RNS
Form 8.5 (EPT/NON-RI) 24-Feb-2025 08:48 RNS
Form 8.5 (EPT/RI) - Poolbeg Pharma Plc 21-Feb-2025 11:53 GlobeNewswire NA
Termination of proposed combination with HOOKIPA 21-Feb-2025 07:00 RNS
HOOKIPA Pharma Inc. (“HOOKIPA”) Stat... 20-Feb-2025 20:06 GlobeNewswire NA
Form 8.5 Poolbeg Pharma Plc 20-Feb-2025 09:03 RNS
Form 8.5 (EPT/NON-RI) 20-Feb-2025 08:53 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Poolbeg Pharma Market Data

Currency UK Pounds
Share Price 3.15p
Change Today -0.60p
% Change -16.00 %
52 Week High 14.25
52 Week Low 2.40
Volume 4,318,655
Shares Issued 500.00m
Market Cap £15.75m
Beta 0.03

Poolbeg Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47.41% below the market average47.41% below the market average47.41% below the market average47.41% below the market average47.41% below the market average
Sector averageSector averageSector averageSector averageSector average
Price Trend
87.93% below the market average87.93% below the market average87.93% below the market average87.93% below the market average87.93% below the market average
65.22% below the sector average65.22% below the sector average65.22% below the sector average65.22% below the sector average65.22% below the sector average
Income Not Available
Growth Not Available

Poolbeg Pharma Dividends

No dividends found

Trades for 29-May-2025

Time Volume / Share Price
16:28 2,997 @ 3.22p
16:16 172 @ 3.03p
16:05 47 @ 3.27p
15:41 460 @ 3.30p
15:41 450 @ 3.00p

Poolbeg Pharma Key Personnel

CEO Jeremy Skillington
CFO Ian O’Connel

Top of Page